ONO Pharmaceutical Co (JP:4528) has released an update.
Ono Pharmaceutical Co., Ltd. is prioritizing corporate governance by increasing management transparency and enhancing board functions, with a focus on flexibility and sound decision-making. The company has appointed specialized outside directors to strengthen governance and has been systematically reducing its cross-shareholdings since 2018, aiming for a ratio under 10% of consolidated net assets. Additionally, Ono Pharmaceutical is committed to promoting diversity and inclusion, with specific goals to increase the representation of women in managerial positions.
For further insights into JP:4528 stock, check out TipRanks’ Stock Analysis page.
